Your browser doesn't support javascript.
loading
Pathogenic compound heterozygous ATP7B mutations with hypoceruloplasminaemia without clinical features of Wilson's disease.
Arruda, Walter O; Munhoz, Renato P; de Bem, Ricardo S; Deguti, Marta M; Barbosa, Egberto Reis; Zavala, Jorge A; Teive, Hélio A G.
  • Arruda WO; Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Rua General Carneiro 1103/102, Centro, Curitiba, PR 80060-150, Brazil.
  • Munhoz RP; Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Rua General Carneiro 1103/102, Centro, Curitiba, PR 80060-150, Brazil.
  • de Bem RS; Gastroenterology and Hepatology Service, Internal Medicine Department, Federal University of Paraná, Curitiba, Brazil.
  • Deguti MM; Department of Hepatology and Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Barbosa ER; Department of Neurology, University of São Paulo School of Medicine, São Paulo, Brazil.
  • Zavala JA; Department of Neurosciences, Alfred Hospital, Melbourne, VIC, Australia.
  • Teive HA; Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Rua General Carneiro 1103/102, Centro, Curitiba, PR 80060-150, Brazil. Electronic address: hagteive@mps.com.br.
J Clin Neurosci ; 21(2): 335-6, 2014 Feb.
Article en En | MEDLINE | ID: mdl-23962630
ABSTRACT
The authors report a 44-year-old man with a history of attention deficit and hyperactivity disorder, obsessive compulsive behaviour, vocal tics, depression, and anxiety, in whom a compound heterozygous ATP7B mutation was found, associated with hypoceruloplasminemia, but without clinical or pathological manifestation of Wilson's disease (WD). Genetic testing revealed a compound heterozygous ATP7B mutation already described in WD, p.Met645Arg (C1934TG/c.51+4A→T). Hypoceruloplasminaemia was detected but no clinical manifestations (hepatic or central nervous system) of WD were present. The authors conclude that patients can carry a heterozygous mutation of the ATP7B gene that is associated with hypoceruloplasminaemia and display no overt clinical hepatic and/or central nervous system manifestations of WD.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ceruloplasmina / Adenosina Trifosfatasas / Trastornos del Metabolismo del Hierro / Enfermedades Neurodegenerativas / Proteínas de Transporte de Catión / Mutación Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ceruloplasmina / Adenosina Trifosfatasas / Trastornos del Metabolismo del Hierro / Enfermedades Neurodegenerativas / Proteínas de Transporte de Catión / Mutación Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Male Idioma: En Año: 2014 Tipo del documento: Article